This site is intended for UK healthcare professionals only

This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website.

Symposium Sponsors

Supporting the NHS to deliver sustainable healthcare solutions

At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology. 

Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs. 

We strive to provide solutions to support high-quality and sustainable healthcare, including for the NHS dispensing surgery community. 

For more information about Daiichi Sankyo visit https://www.daiichi-sankyo.co.uk


Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges.

 

We've been a global leader in diabetes since 1923, and through our research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.

To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.


 Novo is the global healthcare company that believes lasting health starts now. For over a century, we’ve combined leading scientific expertise with a deep understanding of people’s lives. We develop treatments and support that help millions of people make progress they can see, feel and sustain now and in the future. Every day, over 67,000 employees around the world advance our purpose to drive change for lasting health. Through our partnerships, programmes and investments, we’re working to prevent disease, expand access to treatments and reduce our environmental impact to help even more people live healthier lives. For more information, visit novonordisk.co.uk

Stand sponsors

This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website.